Elmind Capital, LP
Filing Date
Global Rank
#2,842
/ 8,232
▲ 291
Top Industry
Biotechnology
94.0%
3Y Alpha vs SPY
-26.2%
Period ended 2 months ago
Filed May 15, 2026 · 29d
2 quarters · since Dec 2025
Clone Performance
Feb 2026–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+1.4%
SPY
+9.1%
Annualised alpha
-26.2%
Max drawdown
−14.5%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
34 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
12.8%
+0.1 pts
Top 5
44.8%
−2.5 pts
Top 10
68.8%
−2.0 pts
HHI
625
Diversified−20
Portfolio Trend
2 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $352,219,180 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
7 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CTMX | CytomX Therapeutics, Inc. | +3,850,000 | 4,550,000 | $21,385,000 | |
| CGEM | Cullinan Therapeutics, Inc. | +220,000 | 530,000 | $7,531,300 | |
| KALV | KalVista Pharmaceuticals, Inc. | +220,000 | 1,021,300 | $20,558,769 | |
| URGN | UroGen Pharma Ltd. | +120,000 | 220,000 | $3,955,600 | |
| TVTX | Travere Therapeutics, Inc. | +67,600 | 177,600 | $5,276,496 | |
| PCVX | Vaxcyte, Inc. | +25,000 | 316,500 | $18,391,815 | |
| UTHR | UNITED THERAPEUTICS Corp | +4,000 | 15,000 | $8,894,700 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
6 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| BCRX | Biocryst Pharmaceuticals Inc | −1,150,000 | 1,000,000 | $9,520,000 | |
| VRDN | Viridian Therapeutics, Inc.DE | −323,700 | 534,931 | $10,463,250 | |
| WVE | Wave Life Sciences Ltd. | −270,000 | 177,846 | $1,289,383 | |
| CGON | CG Oncology, Inc. | −200,700 | 291,800 | $19,749,024 | |
| BMRN | Biomarin Pharmaceutical Inc | −35,000 | 47,000 | $2,655,030 | |
| EWTX | Edgewise Therapeutics, Inc. | −20,000 | 10,000 | $315,000 | |
| No positions match the current search. | |||||
Sold Out
Positions the filer fully exited
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| LQDA | Liquidia Corp | 90,000 | $3,104,100 | |
| No positions match the current search. | ||||
34 positions ·
$352,219,180 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Held | 1,170,740 | $45,061,782 | 12.79% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Held | 1,855,000 | $43,332,800 | 12.30% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Held | 865,000 | $27,437,800 | 7.79% | |
| CTMX |
CytomX Therapeutics, Inc.
Healthcare
|
Added | 4,550,000 | $21,385,000 | 6.07% | |
| KALV |
KalVista Pharmaceuticals, Inc.
Healthcare
|
Added | 1,021,300 | $20,558,769 | 5.84% | |
| CGON |
CG Oncology, Inc.
Healthcare
|
Reduced | 291,800 | $19,749,024 | 5.61% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Held | 482,500 | $19,410,975 | 5.51% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Added | 316,500 | $18,391,815 | 5.22% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Held | 475,750 | $13,439,937 | 3.82% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
Held | 350,000 | $13,405,000 | 3.81% | |
| BEAM |
Beam Therapeutics Inc.
Healthcare
|
Held | 476,338 | $11,351,134 | 3.22% | |
| VRDN |
Viridian Therapeutics, Inc.DE
Healthcare
|
Reduced | 534,931 | $10,463,250 | 2.97% | |
| BCRX |
Biocryst Pharmaceuticals Inc
Healthcare
|
Reduced | 1,000,000 | $9,520,000 | 2.70% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Added | 15,000 | $8,894,700 | 2.53% | |
| CGEM |
Cullinan Therapeutics, Inc.
Healthcare
|
Added | 530,000 | $7,531,300 | 2.14% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
Held | 460,000 | $7,130,000 | 2.02% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
Held | 211,000 | $6,298,350 | 1.79% | |
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
Held | 22,000 | $5,683,040 | 1.61% | |
| DBVT |
DBV Technologies S.A.
Healthcare
|
NEW | 265,000 | $5,535,850 | 1.57% | |
| RLAY |
Relay Therapeutics, Inc.
Healthcare
|
Held | 536,946 | $5,342,612 | 1.52% | |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
Added | 177,600 | $5,276,496 | 1.50% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Held | 38,000 | $4,005,200 | 1.14% | |
| URGN |
UroGen Pharma Ltd.
Healthcare
|
Added | 220,000 | $3,955,600 | 1.12% | |
| ALMS |
Alumis Inc.
Healthcare
|
NEW | 130,000 | $2,863,900 | 0.81% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Reduced | 47,000 | $2,655,030 | 0.75% | |
| DSGN |
Design Therapeutics, Inc.
Healthcare
|
Held | 207,900 | $2,212,056 | 0.63% | |
| APLS |
Apellis Pharmaceuticals, Inc.
Healthcare
|
Held | 50,000 | $2,011,500 | 0.57% | |
| ALEC |
Alector, Inc.
Healthcare
|
Held | 900,000 | $1,935,000 | 0.55% | |
| IMCR |
Immunocore Holdings plc
Healthcare
|
Held | 58,248 | $1,756,177 | 0.50% | |
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
Held | 112,000 | $1,556,800 | 0.44% | |
| ENGN |
enGene Therapeutics Inc.
Healthcare
|
Held | 210,000 | $1,430,100 | 0.41% | |
| WVE |
Wave Life Sciences Ltd.
Healthcare
|
Reduced | 177,846 | $1,289,383 | 0.37% | |
| SUPN |
Supernus Pharmaceuticals, Inc.
Healthcare
|
Held | 20,000 | $1,033,800 | 0.29% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Reduced | 10,000 | $315,000 | 0.09% |